These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20650041)

  • 1. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.
    Liu XW; Li DM; Xu GS; Sun SR
    Int J Clin Pharmacol Ther; 2010 Aug; 48(8):509-13. PubMed ID: 20650041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.
    Liu Y; Qu X; Chen W; Zhang Y; Liu L
    Ren Fail; 2016 Nov; 38(10):1616-1621. PubMed ID: 27819170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):528-31. PubMed ID: 11809115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy].
    Chen X; Chen P; Cai G; Wu J; Cui Y; Zhang Y; Liu S; Tang L
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):796-801. PubMed ID: 12126522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

  • 9. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone.
    Liu X; Dewei D; Sun S; Xu G; Liu H; He L; Zhang P
    Int J Clin Pharmacol Ther; 2014 Feb; 52(2):95-102. PubMed ID: 24161158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
    Zhao M; Chen X; Chen Y; Liu Z; Liu Y; Lu F; Zhang Y; Wang H
    Nephrology (Carlton); 2003 Jun; 8(3):105-9. PubMed ID: 15012724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
    Ni Z; Zhang Z; Yu Z; Lu F; Mei C; Ding X; Yuan W; Zhang W; Jiang G; Sun M; He L; Deng Y; Pang H; Qian J
    Ren Fail; 2021 Dec; 43(1):1214-1221. PubMed ID: 34396911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of leflunomide combined with hormone therapy for refractory IgA nephropathy].
    Rong L; Liu ZR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):893-4. PubMed ID: 17584664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review.
    Chen Y; Li Y; Yang S; Li Y; Liang M
    BMC Nephrol; 2014 Dec; 15():193. PubMed ID: 25475967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of mycophenolate mofetil treatment in IgA nephropathy with proliferative pathological phenotype.
    Liang Y; Zhang J; Liu D; Quan S; Xing G; Liu Z
    Chin Med J (Engl); 2014; 127(1):102-8. PubMed ID: 24384432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
    Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
    Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
    Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
    Yang S; Xie L; Xue W; Yin A; Lu W
    Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.